Clinical Trial Update: Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating whether aggressive blood pressure lowering to modify atrial substrate can prevent atrial fibrillation. The study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED